Search Filters

Search Results

Found 4 results

510(k) Data Aggregation

    K Number
    K221747
    Date Cleared
    2022-12-01

    (168 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Nitrile Patient Examination Gloves Tested For Use With Chemotherapy Drugs

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The nitrile examination glove is intended to be worn on the examiner's hand to prevent contamination between patient and examiner. This is a single-use, powder-free, non-sterile device.

    These gloves were tested for use with chemotherapy drugs per ASTM D6978-05 (2019)Standard Practice for Assessment of Medical Gloves to Permeation by Chemotherapy Drugs. Tested chemotherapy drugs are as follows: Carboplatin, 10 mg/ml >240 min. Carmustine (BCNU), 3.3 mg/ml 27.5 min Cisplatin, 1.0 mg/ml >240 min Cyclophosphamide (Cytoxan), 20.0 mg/ml >240 min Doxorubicin HCI, 2.0 mg/ml >240 min Etoposide, 20.0 mg/ml >240 min Fluorouracil, 50.0 mg/ml >240 min Paclitaxel, 6.0 mg/ml >240 min Thio Tepa, 10.0 mg/ml 88.2 min

    Please note that the following drugs have low permeation times: Carmustine (BCNU) 3.3 mg/ml 27.5 Minutes, Thio Tepa 10.0 mg/ml 88.2 Minutes.

    Warning: Please do not use with Carmustine and Thio Tepa.

    Device Description

    The proposed device (Mode: NG101) is powder free nitrile examination gloves, provided as non-sterile and disposable device. The proposed devices are blue color and there are five sizes, include XS (6.5"), S (7"), M (8"), L (8.5"), XL (9") for optional. The examination glove is smooth surface with textured fingertips and a rolled rim at the cuff edge. This is a single-use, powder-free, non-sterile device.

    The gloves are designed and manufactured in accordance with the ASTM D6319-10 standard and are tested for use with chemotherapy drugs per ASTM D6978-05 (Reapproved 2019)

    AI/ML Overview

    The document describes the non-clinical testing performed to demonstrate that the Nitrile Patient Examination Gloves (K221747) meet their acceptance criteria and are substantially equivalent to a predicate device (K211220).

    1. Table of Acceptance Criteria and Reported Device Performance:

    Test MethodologyPurposeAcceptance CriteriaReported Device Performance
    ASTM D6319-19Physical DimensionThe actual measured dimension of the gloves shall meet the stated tolerance specified in Table 2 of ASTM D6319-19.Meet the requirement
    ASTM D6319-19Determination of Physical PropertiesBefore and after accelerated aging, the gloves shall conform to the physical requirements in Table 3 of ASTM 6319-19 (Tensile Strength: Before Aging ≥ 14 MPa, After Aging ≥ 14 MPa. Elongation: Before Aging 500%, After Aging 400%).Meet the requirement
    ASTM D5151-19Water Leak Test for Detection of HolesThe gloves shall be free from hole when tested in accordance with the method given in ASTM D5151-19, AQL = 2.5.Meet the requirement
    ASTM D6124-06(2017)Residual Powder Content TestThe powder residue content shall be not more than 2mg per glove.Meet the requirement
    ISO 10993-5: 2009In Vitro CytotoxicityThe MEM test extract shows no cytotoxic potential to L929 mouse fibroblast cells.Meet the requirement
    ISO 10993-10: 2010Skin SensitizationThe test article extracts show no evidence of causing delayed dermal contact sensitization in the guinea pig.Meet the requirement
    ISO 10993-10: 2010Skin IrritationThere is no erythema and no edema observed on the skin of the animals treated with the test extracts.Meet the requirement
    ASTM D6978-05 (Chemotherapy Drugs)Chemotherapy Drugs (Permeation Breakthrough Time)Carboplatin, 10 mg/ml >240 min.
    Carmustine (BCNU), 3.3 mg/ml 27.5 min
    Cisplatin, 1.0 mg/ml >240 min
    Cyclophosphamide (Cytoxan), 20.0 mg/ml >240 min
    Doxorubicin HCl, 2.0 mg/ml >240 min
    Etoposide, 20.0 mg/ml >240 min
    Fluorouracil, 50.0 mg/ml >240 min
    Paclitaxel, 6.0 mg/ml >240 min
    Thio Tepa, 10.0 mg/ml 88.2 minExcept for Carmustine and Thio Tepa, acceptance criteria were met.

    2. Sample size used for the test set and the data provenance:

    The document does not explicitly state the sample sizes for each specific test within the non-clinical testing. It generally refers to "Final finished product" as the tested sample. The data provenance is not specified, but it can be inferred that the testing was conducted by or on behalf of the manufacturer, Fitone Latex Products Co., Ltd. Guangdong, which is based in China. The nature of the tests (physical, chemical, and biocompatibility) suggests these were laboratory-based tests on manufactured product samples. The document does not indicate if the data is retrospective or prospective, though it is standard practice for such tests to be prospective assessments of newly manufactured products.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:

    This information is not applicable as the tests described are non-clinical, objective measurements against established ASTM and ISO standards for material properties and performance. There is no human interpretation or expert ground truth establishment for these types of tests (e.g., measuring glove dimensions, tensile strength, or chemical permeation).

    4. Adjudication method for the test set:

    This information is not applicable for the same reason as point 3. Adjudication methods are typically used in studies involving human interpretation or subjective assessments.

    5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:

    This information is not applicable. The submission is for a medical glove, not an AI-powered diagnostic device. Therefore, no MRMC study or AI assistance comparison was conducted.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

    This information is not applicable as the device is not an algorithm or AI-based system.

    7. The type of ground truth used:

    The "ground truth" for the non-clinical tests is based on established industry standards and specifications:

    • ASTM D6319-19 (Standard Specification for Nitrile Examination Gloves for Medical Application)
    • ASTM D5151-19 (Test Method for Detection of Holes in Medical Gloves)
    • ASTM D6124-06(2017) (Test Method for Residual Powder on Medical Gloves)
    • ASTM D573-04(2019) (Test Method for Rubber-Deterioration in an Air Oven)
    • ISO 10993-5: 2009 (Biological Evaluation Of Medical Devices -- Part 5: Tests For In Vitro Cytotoxicity)
    • ISO 10993-10: 2010 (Biological Evaluation Of Medical Devices Part 10: Tests For Irritation And Skin Sensitization)
    • ASTM D6978-05 (Standard Practice for Assessment of Resistance of Medical Gloves to Permeation by Chemotherapy Drugs)

    These standards define the acceptance criteria (e.g., minimum tensile strength, maximum residual powder, breakthrough times for chemotherapy drugs).

    8. The sample size for the training set:

    This information is not applicable as there is no training set for a medical glove. These are physical products tested against predetermined specifications.

    9. How the ground truth for the training set was established:

    This information is not applicable as there is no training set.

    Ask a Question

    Ask a specific question about this device

    K Number
    K213051
    Date Cleared
    2021-12-18

    (87 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The subject device is single use, disposable gloves intended for medical purposes to be worn on the examiner's hands to prevent contamination between patient and examiner. The gloves are powder-free, ambidextrous with beaded cuff, blue colored, nitrile, and tested for use with chemotherapy drugs. The gloves are offered in six sizes: XS, S, M, L, XL, XXL. The subject device is non-sterile.

    AI/ML Overview

    The provided document is a 510(k) premarket notification for Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs). It details the device's technical characteristics, intended use, and performance testing results to demonstrate substantial equivalence to a predicate device.

    Here's the breakdown of the acceptance criteria and study information:

    1. Table of Acceptance Criteria and Reported Device Performance

    The core performance evaluation for these gloves relates to their physical properties, freedom from holes, powder content, biocompatibility, and most importantly, resistance to permeation by chemotherapy drugs.

    Test MethodPerformance CharacteristicAcceptance CriteriaReported Device Performance
    ASTM D6319Physical Dimensions Test
    Length (mm) - XS≥220> 240/Pass
    Length (mm) - S/M/L/XL/XXL≥230> 240/Pass
    Width (mm) - XS70 ± 1067-72/Pass
    Width (mm) - S80 ± 1076-83/Pass
    Width (mm) - M95 ± 1091-99/Pass
    Width (mm) - L110 ± 10106-112/Pass
    Width (mm) - XL120 ± 10116-124/Pass
    Width (mm) - XXL130 ± 10127-134/Pass
    Thickness (mm) - Finger≥0.050.06-0.10/Pass
    Thickness (mm) - Palm≥0.050.07-0.10/Pass
    ASTM D5151Watertightness Test for Detection of HolesMeet the requirements of ASTM D5151 AQL 2.50/125/Pass (This implies 0 holes out of 125 gloves tested, meeting or exceeding AQL 2.5)
    ASTM D6124Powder ContentMeet the requirements of ASTM D6124 ≤ 2.0mg0.02mg/Pass
    ASTM D412Physical Properties (Tensile Strength & Elongation)
    Before Aging:
    Tensile Strength≥14MPa16.4-17.8MPa/Pass
    Ultimate Elongation≥500%533-551%/Pass
    After Aging:
    Tensile Strength≥14MPa15.8-16.8MPa/Pass
    Ultimate Elongation≥400%520-554%/Pass
    ISO 10993-5Biocompatibility - CytotoxicityNon- In Vitro CytotoxicityUnder conditions of the study, device extract is not cytotoxic. /Pass
    ISO 10993-10Biocompatibility - IrritationNon-irritatingUnder the conditions of the study, not an irritant. / Pass
    ISO 10993-10Biocompatibility - SensitizationNon-sensitizingUnder conditions of the study, not a sensitizer. / Pass
    **ASTM D6978-05 (Reapproved 2019) **Chemotherapy Drug Permeation (Minimum Breakthrough Detection Time)
    Carboplatin (10.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Carmustine (BCNU) (3.3 mg/ml)N/A (Comparative to predicate)35.2 Minutes
    Cyclophosphamide (Cytoxan) (20.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Doxorubicin (2.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Etoposide (20.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Fluorouracil (50.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Methotrexate (25.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    Paclitaxel (6.0 mg/ml)N/A (Comparative to predicate)> 240 Minutes
    ThioTepa (10.0 mg/ml)N/A (Comparative to predicate)76.3 Minutes

    Note on Chemotherapy Permeation Acceptance Criteria: The document primarily presents these as reported values and compares them to the predicate device in Table 1 (pages 6-7). The acceptance criteria for these would implicitly be that the breakthrough times are considered sufficient for safe use, or comparable/better than the predicate for equivalent drugs, with a clear warning for drugs with low permeation times. The "Warning: Please do not use with Carmustine (BCNU) and ThioTepa" indicates that the low breakthrough times for these specific drugs are accepted with a cautionary label, rather than requiring an explicit "minimum time" acceptance criterion for regulatory clearance.

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the total sample size for all tests performed. However, it does provide a specific sample size for one critical test:

    • Watertightness Test (ASTM D5151): 125 gloves were tested (indicated by "0/125/Pass").
    • For other tests (e.g., physical dimensions, tensile strength, powder content, biocompatibility, chemotherapy permeation), the specific number of gloves or samples tested is not explicitly stated in the provided summary, although the ASTM standards themselves would specify statistical sampling plans.
    • Data Provenance: The tests were conducted by the manufacturer, Yunnan Huazhiyuan Medical Technology Co., Ltd. The location is China. The studies are retrospective in the sense that they are conducted on manufactured devices to demonstrate compliance with standards for the 510(k) submission, rather than being part of a prospective clinical trial.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This section is not applicable to this type of device and submission. The "ground truth" for the performance of these medical gloves is established through adherence to recognized international and national standards (ASTM, ISO) for physical properties, chemical resistance, and biocompatibility, as measured by laboratory equipment and procedures, not by expert human interpretation or consensus. No human "experts" are interpreting images or clinical data for this non-diagnostic device.

    4. Adjudication Method for the Test Set

    This section is not applicable. Adjudication methods like 2+1 or 3+1 are used in clinical studies, particularly in imaging or diagnostic device evaluations where multiple readers interpret data and discrepancies need to be resolved. For laboratory bench testing against physical and chemical standards, there is no human interpretation needing adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    This section is not applicable. MRMC studies are specific to diagnostic devices, especially those involving image interpretation by multiple human readers, to assess the impact of an AI algorithm on reader performance. This device is a medical glove, a Class I non-diagnostic device, and its performance is evaluated through bench testing against established standards, not human reader studies.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    This section is not applicable. This device is not an algorithm or AI-based product. Its performance is entirely standalone in the sense that its physical and chemical properties are measured directly from the device itself.

    7. The Type of Ground Truth Used

    The "ground truth" for this device's performance is based entirely on laboratory bench testing results measured against predefined acceptance criteria established by recognized international standards (ASTM and ISO).

    • Physical properties: Measured dimensions, tensile strength, elongation.
    • Freedom from holes: Tested using a water-tightness test.
    • Powder content: Measured residual powder.
    • Biocompatibility: In vitro cytotoxicity, irritation, and sensitization tests.
    • Chemotherapy drug permeation: Measured breakthrough times using specific chemical assays as per ASTM D6978-05.

    8. The Sample Size for the Training Set

    This section is not applicable. This is a physical medical device, not an AI/ML algorithm that requires a training set. The "training" for the device's manufacturing process would be based on quality control and manufacturing specifications, not a data training set.

    9. How the Ground Truth for the Training Set Was Established

    This section is not applicable as it pertains to AI/ML devices.

    Ask a Question

    Ask a specific question about this device

    K Number
    K213048
    Date Cleared
    2021-12-18

    (87 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs)

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    A patient examination gloves is a disposable device intended for medical purpose that is worn on the examiner's hand or fingers to prevent contamination between patient and examiner. In addition, these gloves were tested for use with chemotherapy drugs in accordance with ASTM D6978-05 Standard Practice for Assessment of Medical gloves to Permeation by Chemotherapy Drugs.

    Device Description

    The subject device is single use, disposable gloves intended for medical purposes to be worn on the examiner's hands to prevent contamination between patient and examiner. The gloves are powder-free, ambidextrous with beaded cuff, blue colored, nitrile, and tested for use with chemotherapy drugs. The gloves are offered in six sizes: XS, S, M, L, XL, XXL. The subject device is non-sterile.

    AI/ML Overview

    This document describes the safety and performance of Nitrile Patient Examination Gloves (Tested for Use with Chemotherapy Drugs) as submitted for FDA 510(k) clearance (K213048). The study focuses exclusively on comprehensive bench testing and biocompatibility assessments, demonstrating the device's adherence to established standards for medical gloves, particularly regarding chemotherapy drug permeation.

    1. Table of Acceptance Criteria and Reported Device Performance

    Test MethodPurposeAcceptance CriteriaReported Device Performance
    ASTM D6319Physical Dimensions TestLength (mm):
    XS: ≥220;
    S/M/L/XL/XXL: ≥230
    Width (mm):
    XS: 70±10;
    S: 80±10;
    M: 95±10;
    L: 110±10;
    XL: 120±10;
    XXL: 130±10
    Thickness (mm):
    Finger: ≥0.05;
    Palm: ≥0.05Length (mm):
    All sizes: > 240/Pass
    Width (mm):
    XS: 80-83/Pass
    S: 86-90/Pass
    M: 97-98/Pass
    L: 108-112/Pass
    XL: 115-120/Pass
    XXL: 128-130/Pass
    Thickness (mm):
    Finger: 0.08-0.10/Pass
    Palm: 0.08-0.11/Pass
    ASTM D5151Watertightness Test for Detection of HolesMeet the requirements of ASTM D5151 AQL 2.50/125/Pass (This implies that out of 125 samples tested, 0 failed, meeting AQL 2.5)
    ASTM D6124Powder ContentMeet the requirements of ASTM D6124 240 minutes for many drugs, but lower times are accepted for certain highly permeable drugs, provided they are clearly labeled with warnings.Carboplatin: > 240 Minutes
    Carmustine (BCNU): 26.5 Minutes (Warning advised)
    Cyclophosphamide: > 240 Minutes
    Doxorubicin: > 240 Minutes
    Etoposide: > 240 Minutes
    Fluorouracil: > 240 Minutes
    Methotrexate: > 240 Minutes
    Paclitaxel: > 240 Minutes
    ThioTepa: 48.4 Minutes (Warning advised)

    2. Sample Sizes Used for the Test Set and Data Provenance

    The document does not explicitly state the specific number of units (gloves) for each test, but it does refer to meeting ASTM standards, which would imply a scientifically sound sampling methodology.
    For the Watertightness Test, the results state "0/125/Pass," indicating a sample size of 125 units was tested for holes.
    The data provenance is based on non-clinical laboratory testing (bench testing) performed by or for Huayuan Medical Technology (Shangqiu) Co., Ltd. The specific location of testing is not detailed beyond the company's address in Shangqiu City, Henan Province, China. The data would be considered prospective for the purposes of this 510(k) submission, as these tests were conducted to demonstrate compliance for the specific device.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    Not applicable. This submission relies on objective, standardized bench tests (e.g., ASTM, ISO standards) to establish performance. The "ground truth" is defined by the technical specifications and criteria outlined in these industry-recognized standards, rather than expert consensus on subjective data (like image interpretation in AI/clinical studies). No human experts were used to establish ground truth in the context of clinical/radiological assessment. The experts involved would be laboratory technicians and engineers qualified to perform and interpret the specified physical, chemical, and biological tests according to the standards.

    4. Adjudication Method for the Test Set

    Not applicable. Since the study involves objective bench testing against pre-defined acceptance criteria from international standards (ASTM, ISO), no human adjudication of test results is typically required beyond standard quality control and verification procedures of the testing laboratory.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done

    No. This K213048 submission is for Nitrile Patient Examination Gloves, which are a physical medical device, not a diagnostic imaging AI system. Therefore, an MRMC comparative effectiveness study, which is relevant for evaluating the impact of AI on human reader performance in diagnostic tasks, was not performed. The study focuses on the physical and chemical properties of the gloves.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study was done

    Not applicable. This is not an AI-powered diagnostic device or software. The "performance" being assessed is the physical and chemical resistance of the gloves, which is inherently a standalone performance of the material and manufacturing process under controlled laboratory conditions.

    7. The Type of Ground Truth Used

    The "ground truth" for this device is established by objective laboratory measurements against pre-defined technical specifications and performance criteria set forth in internationally recognized standards (ASTM D6319, ASTM D5151, ASTM D6124, ASTM D412, ASTM D6978-05, ISO 10993-5, ISO 10993-10). For example, the ground truth for "tensile strength" is a measured force in MPa, which is then compared to an acceptance criterion (e.g., ≥14MPa). For chemotherapy drug permeation, the ground truth is the measured breakthrough time in minutes.

    8. The Sample Size for the Training Set

    Not applicable. This is a traditional medical device (gloves), not an AI/machine learning model. Therefore, there is no "training set." The manufacturing process for physical gloves does not involve machine learning training.

    9. How the Ground Truth for the Training Set was Established

    Not applicable, as there is no training set for a physical device like examination gloves.

    Ask a Question

    Ask a specific question about this device

    K Number
    K083408
    Date Cleared
    2009-07-31

    (255 days)

    Product Code
    Regulation Number
    880.6250
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    POWDER FREE NITRILE PATIENT EXAMINATION GLOVES, TESTED FOR USE WITH CHEMOTHERAPY DRUGS

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The powder free chemotherapy examination glove is a specialty medical glove which is a disposable device intended for medical purposes that is worn on the examiner's hand or forefinger to prevent contamination between examiner and patient bodily fluids, waste or environment. Tested for use with chemotherapy drugs. Tested chemotherapy drugs are as follows [Carmustine (BiCNU). Thio-Tepa. Cyclophosphamide, Dacarbazine, Doxorubicin Hydrochloride; 5- Fluorouracil, Cisplatin, Etoposide and Paclitaxel].

    WARNING: DO NOT USE THESE GLOVES WITH THIO-TEPA CAUTION: Testing showed an average breakthrough time of less than 60 minutes with Carmustine.

    Device Description

    Powder Free Blue Nitrile Patient Examination Gloves, Tested for use with Chemotherapy Drugs meet all the requirements of ASTM standard D6978-05, D5712-05e1 and FDA 21 CFR 880.6250.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study information for the "Powder Free Blue Nitrile Patient Examination Gloves, Tested for use with Chemotherapy Drugs," based on the provided 510(k) summary:

    1. Table of Acceptance Criteria and Reported Device Performance

    CharacteristicAcceptance Criteria (Standard)Reported Device Performance
    DimensionsASTM D6319-00aMeets
    Physical PropertiesASTM D6319-00aMeets
    ThicknessASTM D6319-00aMeets
    Powder FreeASTM D6124-01Meets (≤ 2 mg/glove)
    Biocompatibility (Primary Skin Irritation)- (Implied standard)Passes (Not a primary skin irritant)
    Biocompatibility (Dermal Sensitization)ASTM F-720-81Passes (Not a contact sensitizer)
    Watertight (1000ml)ASTM D5151-06Passes
    Resistance to permeation by Chemotherapy DrugsASTM D6978-05Meets requirement

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not explicitly state the specific sample sizes used for each test (dimensions, physical properties, etc.). However, it refers to ASTM standards, which typically outline sampling plans.

    • Data Provenance: The document does not specify the country of origin for the data or whether the studies were retrospective or prospective. It is implied the testing was conducted by the manufacturer (WRP Asia Pacific Sdn Bhd in Malaysia) to meet international standards.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This information is not applicable to this type of device and study. The "ground truth" for the performance characteristics of examination gloves is established through objective physical and chemical testing against recognized industry standards (e.g., ASTM standards), not through expert consensus or interpretation of medical images/data.

    4. Adjudication Method for the Test Set

    This information is not applicable as there were no subjective assessments requiring adjudication. The tests conducted are objective measurements against predefined criteria.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC comparative effectiveness study was not done. This type of study is typically performed for diagnostic imaging devices where human readers interpret results, often with and without AI assistance. This device is an examination glove, which does not involve human interpretation in the same manner.

    6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

    Yes, a standalone performance evaluation was conducted. The device (the glove) itself was tested against the various ASTM standards and performance criteria. There is no "algorithm" or "human-in-the-loop" component in the functionality of an examination glove beyond its intended physical properties.

    7. The Type of Ground Truth Used

    The ground truth used for this device's testing is based on objective, standardized measurements and criteria defined by established industry standards (ASTM). For example:

    • Physical measurements (dimensions, thickness)
    • Chemical analysis (powder content)
    • Biocompatibility assays (skin irritation, sensitization)
    • Barrier integrity tests (watertightness, chemotherapy drug permeation)

    8. The Sample Size for the Training Set

    This information is not applicable. This device is not an AI/ML-based system that requires a "training set" in the conventional sense. The manufacturing process and quality control would involve ongoing testing, but there isn't a "training set" like there would be for an algorithmic model.

    9. How the Ground Truth for the Training Set Was Established

    This information is not applicable for the reasons stated in point 8.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1